Obesity Clinical Trial
Official title:
Randomized Study of Daytime vs. Delayed Eating: Effect on Weight and Metabolism
The purpose of this study is to determine if, controlling for eating and sleep timing, caloric intake, and exercise, daytime vs. delayed eating affects body mass, adiposity, and energy metabolism in healthy adults.
The study consists of 4 phases - screening & baseline assessment, eating condition 1,
wash-out period, and eating condition 2. Before and after each phase participants will
complete a 28-hour inpatient assessment at the Clinical and Translational Research Center
(CTRC) of the Hospital of the University of Pennsylvania to study the impact of one's eating
on body weight and fat content, metabolism, and certain markers of metabolism in the blood.
Screening In order to participate in this study the participants must undergo a complete
physical examination and tests of blood and urine. These tests will determine if participants
have any conditions that would prevent them from participating in the study, including
diabetes or any serious uncontrolled medical condition that may interfere with their
participation in the study. Other conditions that would prevent them from taking part are
pregnancy or nursing, a sleep disorder, the use of certain medications, or night-shift work.
A urine pregnancy test will be given to women at this screening visit.
Participants will also complete several surveys of a psychological nature and participate in
a clinical interview. Sleep and exercise schedules are important and will be reviewed during
their visits to see if they match with the study requirements. During the 10 days of the
screening assessment, participants will keep a log in which they will record all food and
beverages that they consume. They will also use these logs to record when they sleep and
exercise. Their activity will be measured by a small electronic wrist activity recorder,
called an Actigraph (about the size of a wrist watch), during this time. This recorder,
similar to a pedometer, records all activity from the arm, and is very useful in determining
if and when they get up at night. Study staff will explain how to keep this information
during the baseline visit. They will return the activity recorder and log to Dr. Allison for
analysis at the end of the 10-days. They are expected to return all study materials,
including the Actigraph, log, and questionnaires.
Assessments Following successful completion of the screening period, they will complete the
first of four assessment visits. This visit will include 28 hours (overnight) spent at the
CTRC, where their meals and snacks will be provided.
They will arrive at the CTRC at the Hospital of the University of Pennsylvania at 7 AM.
Starting at 8 AM, their blood will be drawn every four hours. A thin needle (an introducer)
will be inserted into a vein in their forearm, much like an IV line. Very small blood
samples, 10mL (2 teaspoonfuls), will be collected every four hours from 8:00 AM on Day 1
through 8:00 AM on Day 2. From this blood study staff will measure hormones related to
metabolism, sleep, and stress. They will be provided meals and snacks during this time, and
they are free to watch television or use their computer or participate in other sedentary
pastimes while they are there.
After the blood draws end at 8 AM on the second morning, their metabolic rate will be
measured. Participants will be asked to fast for 10 hours overnight (they will not be able to
eat or drink anything except water for 10 hours starting at 10 PM the night before). Then
study staff will measure their resting metabolic rate for 20 minutes. During the
measurements, they will lay on their back in bed with a plastic hood/canopy over their head
and neck. They will lay still and breathe normally while the air they inhale and exhale is
collected in the canopy/hood and analyzed using a machine that is connected to the
canopy/hood.
Participants will be discharged from the hospital, and research staff will escort them to the
Center for Weight and Eating Disorders where their body composition will be measured using
dual energy X-ray absorptiometry (DEXA). During this test, X-ray pictures of their body will
measure how much fat and muscle are present. They will lie flat on a table and a machine will
take pictures of different areas of the body. This test will last about 30 minutes. This will
conclude the assessment visit.
Eating Conditions & Assessments Upon completion of the baseline assessment, participants will
be randomly assigned to start with one of two eating conditions: 1) Daytime or 2) Delayed,
and then they will switch and eat on the other schedule for the final part of the study. If
they are assigned to the Daytime eating condition first, they will be asked to consume all of
their meals and snacks each day between 8 AM and 7 PM. If they are assigned to the Delayed
eating condition first, they will be asked to consume all of their meals and snacks between
12 PM and 11 PM each day. They will eat on these schedules for 8 weeks each.
During the two 8-week eating condition periods, all of their meals and snacks will be
provided by the research kitchen and will be delivered to themby a member of the research
staff twice per week. They will be provided a personalized menu and asked to track each food
item they consume. They will also be asked to record any beverages they consume on this menu
(beverages will not be provided). If occasionally they do not eat the meals provided, they
will be asked to use their smart phone or electronic device to send a picture of their food
to the study team before they eat it, and again if any food is not eaten when they have
finished their meal. They will be asked to wear an Actigraph for the duration of the study,
and study staff will deliver new devices and collect used devices one time per week. They
will be sent and asked to respond to daily queries by text message or email regarding their
eating, sleeping, and exercise. At the end of the 8 weeks, they will complete the second
overnight assessment visit (as described above).
For two weeks following this second assessment, they will be asked to eat as they normally
would. During this "wash-out" period they will eat what and when then would like. They will
then complete the third overnight assessment visit before starting the second eating
condition (Delayed for those initially assigned to the Daytime schedule; Daytime for those
initially assigned to the Delayed schedule). They will be asked to eat on this new schedule
for 8 weeks. They will then complete the fourth and final overnight assessment. After this
final assessment visit, their participation in the study will be complete.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |